Clinical Evaluation of Microhybrid Composites in Noncarious Cervical Lesions: 24-Month Results

dc.contributor.authorTuncer, D.
dc.contributor.authorCelik, C.
dc.contributor.authorYamanel, K.
dc.contributor.authorArhun, N.
dc.contributor.orcID0000-0002-5936-0196en_US
dc.contributor.pubmedID28091433en_US
dc.contributor.researcherIDR-2536-2019en_US
dc.contributor.researcherIDAAA-1576-2021en_US
dc.date.accessioned2023-07-21T07:29:43Z
dc.date.available2023-07-21T07:29:43Z
dc.date.issued2017
dc.description.abstractObjective: To evaluate the clinical performance of two different microhybrid resin composites in noncarious cervical lesions (NCCLs) after 24 months. Subjects and Methods: Ninety-seven NCCLs were restored with either TPH Spectrum (n = 48) or Filtek Z250 (n = 49) using an etch-and-rinse adhesive in 20 patients. The restorations were clinically evaluated using modified United States Public Health Service criteria for retention, color match, marginal discoloration, marginal adaptation, surface texture, anatomic form, postoperative sensitivity, and secondary caries. The restorations were assessed 1 week after placement (baseline) and after 6, 12, and 24 months. Restoration survival rates were calculated using the Kaplan-Meier procedure estimator, and a log-rank test was used to compare the survival distributions (P < 0.05). Statistical analysis was undertaken using Pearson's Chi-square test and Fisher's exact test to assess differences among the restorative materials (P < 0.05). Cochran's Q-test was employed for evaluating differences in the same restorative material between recall periods. Results: The retention rates were 100% at 6 months, 89.6% and 91.8% at 12 months, and 85.4% and 89.8% at 24 months for TPH and Z250, respectively. TPH showed a statistically significant difference in marginal discoloration between the baseline and 24 months results (P < 0.05). Both TPH and Z250 showed statistically significant differences in marginal adaptation between the baseline and 24 months results (P < 0.05). Conclusion: Over the 24-month period, both microhybrid resin composites demonstrated acceptable clinical results in NCCLs.en_US
dc.identifier.endpage181en_US
dc.identifier.issn1119-3077en_US
dc.identifier.issue2en_US
dc.identifier.scopus2-s2.0-85010004778en_US
dc.identifier.startpage176en_US
dc.identifier.urihttp://hdl.handle.net/11727/10029
dc.identifier.volume20en_US
dc.identifier.wos000395404700009en_US
dc.language.isoengen_US
dc.relation.isversionof10.4103/1119-3077.178913en_US
dc.relation.journalNIGERIAN JOURNAL OF CLINICAL PRACTICEen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergien_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subjectClinical evaluationen_US
dc.subjectmicrohybrid resin compositesen_US
dc.subjectmodified United States Public Health Service criteriaen_US
dc.subjectnoncarious cervical lesionsen_US
dc.titleClinical Evaluation of Microhybrid Composites in Noncarious Cervical Lesions: 24-Month Resultsen_US
dc.typeArticleen_US

Files

License bundle

Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.71 KB
Format:
Item-specific license agreed upon to submission
Description: